Company intelligence / Profile preview

Renata

Dhaka, Dhaka, Bangladeshrenata.com ↗

Ownership: Private
Employees: ~11000
Development stage: Commercial

Overview

Renata has established itself as one of Bangladesh's leading pharmaceutical manufacturers with strong export capabilities. It holds approvals from stringent regulatory agencies such as the US FDA, UK MHRA, TGA Australia, Health Canada, ANVISA Brazil, WHO PQP/UNICEF for various facilities/products. The company exports to over 40 countries with an expanding pipeline focused on regulated markets like the EU and US. Recent clinical milestones include approval for an anti-Parkinson’s drug in Germany; seven drugs are currently approved in the US market.

Therapeutic areas: OncologyPulmonologyEndocrinologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeBiologicVaccine
Industry: Biotech

Partnerships

GAIN (Global Alliance for Improved Nutrition)BRAC

Beyond the preview

Go deeper on Renata.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renata.

Explore the full profile